Search research articles
Contact Us
Filters
Showing results (291-300 of 307) with videos related to
Page
of 31
Sort By:
BMJ (Clinical Research Ed.)
|
November 2, 2018
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
David S Kessler, Stephanie J MacNeill, Deborah Tallon, et al.
Pain
|
April 2, 2019
Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy
Rajesh Khanna, Jie Yu, Xiaofang Yang, et al.
Pain
|
September 1, 2018
Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels
Shreya S Bellampalli, Yingshi Ji, Aubin Moutal, et al.
Pilot and Feasibility Studies
|
February 4, 2022
The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation-the Community Pharmacies Mood Intervention Study (CHEMIST)
Carolyn A Chew-Graham, Charlotte E W Kitchen, Samantha Gascoyne, et al.
Gigascience
|
August 18, 2025
A near telomere-to-telomere phased genome assembly and annotation for the Australian central bearded dragon Pogona vitticeps
Hardip R Patel, Kirat Alreja, Andre L M Reis, et al.
Plos Medicine
|
October 12, 2021
Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Science Translational Medicine
|
November 10, 2021
Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents
Song Cai, Aubin Moutal, Jie Yu, et al.
Plos One
|
March 24, 2022
Behavioural Activation for Social IsoLation (BASIL+) trial (Behavioural activation to mitigate depression and loneliness among older people with long-term conditions): Protocol for a fully-powered pragmatic randomised controlled trial
Lauren Burke, Elizabeth Littlewood, Samantha Gascoyne, et al.
Health Technology Assessment (Winchester, England)
|
March 31, 2025
A group psychological intervention for postnatal depression in British mothers of South Asian origin - the ROSHNI-2 RCT
Nusrat Husain, Karina Lovell, Carolyn A Chew-Graham, et al.
Lancet (London, England)
|
October 13, 2024
Efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women (ROSHNI-2): a multicentre, randomised controlled trial
Nusrat Husain, Farah Lunat, Karina Lovell, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 307) with videos related to
Sort By:
Page
of 31
BMJ (Clinical Research Ed.)
|
November 2, 2018
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
David S Kessler, Stephanie J MacNeill, Deborah Tallon, et al.
Pain
|
April 2, 2019
Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy
Rajesh Khanna, Jie Yu, Xiaofang Yang, et al.
Pain
|
September 1, 2018
Betulinic acid, derived from the desert lavender Hyptis emoryi, attenuates paclitaxel-, HIV-, and nerve injury-associated peripheral sensory neuropathy via block of N- and T-type calcium channels
Shreya S Bellampalli, Yingshi Ji, Aubin Moutal, et al.
Pilot and Feasibility Studies
|
February 4, 2022
The feasibility and acceptability of a brief psychological intervention for adults with long-term health conditions and subthreshold depression delivered via community pharmacies: a mixed methods evaluation-the Community Pharmacies Mood Intervention Study (CHEMIST)
Carolyn A Chew-Graham, Charlotte E W Kitchen, Samantha Gascoyne, et al.
Gigascience
|
August 18, 2025
A near telomere-to-telomere phased genome assembly and annotation for the Australian central bearded dragon Pogona vitticeps
Hardip R Patel, Kirat Alreja, Andre L M Reis, et al.
Plos Medicine
|
October 12, 2021
Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial
Simon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Science Translational Medicine
|
November 10, 2021
Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents
Song Cai, Aubin Moutal, Jie Yu, et al.
Plos One
|
March 24, 2022
Behavioural Activation for Social IsoLation (BASIL+) trial (Behavioural activation to mitigate depression and loneliness among older people with long-term conditions): Protocol for a fully-powered pragmatic randomised controlled trial
Lauren Burke, Elizabeth Littlewood, Samantha Gascoyne, et al.
Health Technology Assessment (Winchester, England)
|
March 31, 2025
A group psychological intervention for postnatal depression in British mothers of South Asian origin - the ROSHNI-2 RCT
Nusrat Husain, Karina Lovell, Carolyn A Chew-Graham, et al.
Lancet (London, England)
|
October 13, 2024
Efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women (ROSHNI-2): a multicentre, randomised controlled trial
Nusrat Husain, Farah Lunat, Karina Lovell, et al.
Page
of 31